We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$408M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
246
Reduced
378
Closed
79
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Omnicom Group
OMC
$22.1B
| $382M | 0.57% |
4,904,568
-123,941
| -2% | -$9.46M |
2013 Q2
7 quarters
|
|
52
EOG Resources
EOG
$80.1B
| $377M | 0.56% |
4,111,969
-304,138
| -7% | -$27.5M |
2013 Q2
7 quarters
|
|
53
Zimmer Biomet
ZBH
$18B
| $375M | 0.56% |
3,282,511
+26,054
| +0.8% | +$2.97M |
2014 Q1
4 quarters
|
|
54
International Paper
IP
$18.1B
| $371M | 0.55% |
7,055,556
-234,590
| -3% | -$12.2M |
2013 Q2
7 quarters
|
|
55
Prudential Financial
PRU
$40.1B
| $369M | 0.55% |
4,596,457
+232,732
| +5% | +$18.9M |
2013 Q2
7 quarters
|
|
|
56
Comcast
CMCSA
$77.3B
| $360M | 0.54% |
12,749,404
-11,215,792
| -47% | -$322M |
2013 Q2
7 quarters
|
|
57
NXP Semiconductors
NXPI
$58.3B
| $350M | 0.52% |
3,492,390
+11,510
| +0.3% | +$1.01M |
2014 Q4
1 quarter
|
|
58
Huntsman Corp
HUN
$1.5B
| $350M | 0.52% |
15,799,456
-370,884
| -2% | -$8.28M |
2013 Q2
7 quarters
|
|
59
Verizon
VZ
$184B
| $349M | 0.52% |
7,178,566
-205,244
| -3% | -$9.91M |
2014 Q2
3 quarters
|
|
60
Elevance Health
ELV
$92.9B
| $345M | 0.51% |
2,235,780
+1,739,509
| +351% | +$248M |
2013 Q2
7 quarters
|
|
|
61
Trane Technologies
TT
$101B
| $336M | 0.5% |
+4,929,075
| New | +$326M |
2015 Q1
0 quarters
|
|
62
The Gap Inc
GAP
$8.24B
| $330M | 0.49% |
7,625,488
-366,445
| -5% | -$15.3M |
2014 Q2
3 quarters
|
|
|
XL
63
DELISTED
XL Group Ltd.
XL
| $326M | 0.49% |
8,856,540
+6,757,636
| +322% | +$242M |
2014 Q1
4 quarters
|
|
64
Avery Dennison
AVY
$13.3B
| $304M | 0.45% |
5,752,042
-659,705
| -10% | -$34.9M |
2014 Q2
3 quarters
|
|
65
Raymond James Financial
RJF
$30.3B
| $304M | 0.45% |
8,018,181
+1,115,113
| +16% | +$41.7M |
2013 Q2
7 quarters
|
|
|
66
DELISTED
Anadarko Petroleum
APC
| $303M | 0.45% |
+3,658,508
| New | +$299M |
2015 Q1
0 quarters
|
|
67
Amgen
AMGN
$235B
| $298M | 0.44% |
1,862,303
+41,146
| +2% | +$6.48M |
2013 Q2
7 quarters
|
|
68
Amdocs
DOX
$6.34B
| $297M | 0.44% |
5,454,632
+233,630
| +4% | +$11.8M |
2013 Q2
7 quarters
|
|
|
QEP
69
DELISTED
QEP RESOURCES, INC.
QEP
| $291M | 0.43% |
13,937,577
-517,454
| -4% | -$10.8M |
2014 Q1
4 quarters
|
|
70
Robert Half
RHI
$3.52B
| $290M | 0.43% |
4,787,797
+368,623
| +8% | +$22.2M |
2013 Q2
7 quarters
|
|
71
Parker-Hannifin
PH
$121B
| $282M | 0.42% |
2,371,967
+112,810
| +5% | +$13.7M |
2013 Q2
7 quarters
|
|
72
Cardinal Health
CAH
$58.7B
| $281M | 0.42% |
3,110,481
+111,804
| +4% | +$9.63M |
2013 Q2
7 quarters
|
|
73
MetLife
MET
$63.7B
| $276M | 0.41% |
6,129,466
-232,638
| -4% | -$10.5M |
2013 Q2
7 quarters
|
|
74
DELISTED
TD Ameritrade Holding Corp
AMTD
| $274M | 0.41% |
7,363,845
+178,511
| +2% | +$6.35M |
2013 Q2
7 quarters
|
|
75
Arrow Electronics
ARW
$11.2B
| $273M | 0.41% |
4,464,762
-334,593
| -7% | -$19.9M |
2013 Q2
7 quarters
|
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 246 increased, 378 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.